Zsolt Kőszegi

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Fractional Flow Reserve Calculation From 3-Dimensional Quantitative Coronary Angiography and TIMI Frame Count

Shengxian Tu, Emanuele Barbato, Zsolt Kőszegi et al. · JACC: Cardiovascular Interventions · 2014 · 355 citations

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study

Ply Chichareon, Rodrigo Modolo, Norihiro Kogame et al. · Atherosclerosis · 2020 · 78 citations · Full text

Percutaneous Coronary Intervention, Diabetes Management, Cardiovascular Epidemiology +11

Various clinical scenarios leading to development of the string sign of the internal thoracic artery after coronary bypass surgery: the role of competitive flow, a case series

Rudolf Kolozsvári, Zoltán Galajda, Tamás Ungvári et al. · Journal of Cardiothoracic Surgery · 2012 · 27 citations · Full text